Insider Trading Alert - MPW, FIVE And TJX Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Sept. 12, 2014, 84 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $10,031,220.00.

Highlighted Stocks Traded by Insiders:

Medical Properties (MPW) - FREE Research Report

Aldag Edward K JR, who is Chairman, President and CEO at Medical Properties, sold 45,360 shares at $13.30 on Sept. 12, 2014. Following this transaction, the Chairman, President and CEO owned 2.3 million shares meaning that the stake was reduced by 1.98% with the 45,360-share transaction.

The shares most recently traded at $13.05, down $0.25, or 1.92% since the insider transaction. Historical insider transactions for Medical Properties go as follows:

  • 4-Week # shares sold: 30,000
  • 12-Week # shares sold: 30,000
  • 24-Week # shares sold: 109,760

The average volume for Medical Properties has been 1.2 million shares per day over the past 30 days. Medical Properties has a market cap of $2.4 billion and is part of the financial sector and real estate industry. Shares are up 7.61% year-to-date as of the close of trading on Friday.

Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers. The stock currently has a dividend yield of 6.19%. The company has a P/E ratio of 48.5. Currently, there are 2 analysts who rate Medical Properties a buy, 2 analysts rate it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPW - FREE

TheStreet Quant Ratings rates Medical Properties as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Medical Properties Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Five Below (FIVE) - FREE Research Report

Schlessinger David, who is Executive Chairman at Five Below, sold 78,900 shares at $42.32 on Sept. 12, 2014. Following this transaction, the Executive Chairman owned 655,810 shares meaning that the stake was reduced by 10.74% with the 78,900-share transaction.

The shares most recently traded at $42.99, up $0.67, or 1.57% since the insider transaction. Historical insider transactions for Five Below go as follows:

  • 4-Week # shares sold: 121,100
  • 12-Week # shares sold: 221,100
  • 24-Week # shares sold: 346,100

The average volume for Five Below has been 880,700 shares per day over the past 30 days. Five Below has a market cap of $2.3 billion and is part of the services sector and specialty retail industry. Shares are up 0.38% year-to-date as of the close of trading on Friday.

Five Below, Inc. operates as a specialty value retailer in the United States. The company offers various products priced at $5 and below. The company has a P/E ratio of 61.5. Currently, there are 9 analysts who rate Five Below a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FIVE - FREE

TheStreet Quant Ratings rates Five Below as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, premium valuation and poor profit margins. Get the full Five Below Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TJX Companies (TJX) - FREE Research Report

Herrman Ernie, who is President at TJX Companies, sold 58,135 shares at $59.79 on Sept. 12, 2014. Following this transaction, the President owned 390,000 shares meaning that the stake was reduced by 12.97% with the 58,135-share transaction.

The shares most recently traded at $59.86, up $0.07, or 0.12% since the insider transaction. Historical insider transactions for TJX Companies go as follows:

  • 4-Week # shares sold: 219,312
  • 12-Week # shares bought: 31,656
  • 12-Week # shares sold: 219,312
  • 24-Week # shares bought: 31,656
  • 24-Week # shares sold: 269,312

The average volume for TJX Companies has been 4.3 million shares per day over the past 30 days. TJX Companies has a market cap of $41.7 billion and is part of the services sector and retail industry. Shares are down 6.03% year-to-date as of the close of trading on Friday.

The TJX Companies, Inc. operates as an off-price apparel and home fashions retailer in the United States and internationally. The company operates in four segments: Marmaxx, HomeGoods, TJX Canada, and TJX Europe. The stock currently has a dividend yield of 1.16%. The company has a P/E ratio of 19.9. Currently, there are 11 analysts who rate TJX Companies a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TJX - FREE

TheStreet Quant Ratings rates TJX Companies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full TJX Companies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Tesla Jumps on Model 3 Expansion Hopes, China Trade Truce

Tesla Jumps on Model 3 Expansion Hopes, China Trade Truce

Apple Gains as U.S. China Trade Tensions Ease After Weekend Summit

Apple Gains as U.S. China Trade Tensions Ease After Weekend Summit

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO